2021 ESMO临床实践指南:成人癌症患者临终护理

2021-08-17 欧洲肿瘤内科学会 ESMO Open

2021年8月,欧洲肿瘤内科学会(ESMO)发布了成人癌症患者临终护理指南,在生命终末期,护理的目标主要为舒适,提供个体化的生活质量管理,本文主要针对成人癌症患者临终护理的相关内容提供指导建议。

中文标题:

2021 ESMO临床实践指南:成人癌症患者临终护理

英文标题:

Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines

发布机构:

欧洲肿瘤内科学会

发布日期:

2021-08-17

简要介绍:

2021年8月,欧洲肿瘤内科学会(ESMO)发布了成人癌症患者临终护理指南,在生命终末期,护理的目标主要为舒适,提供个体化的生活质量管理,本文主要针对成人癌症患者临终护理的相关内容提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ESMO临床实践指南:成人癌症患者临终护理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=12e541c00221223a, title=2021 ESMO临床实践指南:成人癌症患者临终护理, enTitle=Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines, guiderFrom=ESMO Open, authorId=0, author=, summary=2021年8月,欧洲肿瘤内科学会(ESMO)发布了成人癌症患者临终护理指南,在生命终末期,护理的目标主要为舒适,提供个体化的生活质量管理,本文主要针对成人癌症患者临终护理的相关内容提供指导建议。, cover=https://img.medsci.cn/20211016/1634393588516_5579292.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology )是1975年成立的非盈利组织,是欧洲领先的专业组织,致力于提高肿瘤内科的专业性,推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Tue Aug 17 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月,欧洲肿瘤内科学会(ESMO)发布了成人癌症患者临终护理指南,在生命终末期,护理的目标主要为舒适,提供个体化的生活质量管理,本文主要针对成人癌症患者临终护理的相关内容提供指导建议。</span></p>, tagList=[TagDto(tagId=116114, tagName=成人癌症患者)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=116114, guiderKeyword=成人癌症患者, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5557, appHits=139, showAppHits=0, pcHits=1520, showPcHits=5418, likes=2, shares=17, comments=12, approvalStatus=1, publishedTime=Sun Oct 17 23:05:42 CST 2021, publishedTimeString=2021-08-17, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Oct 17 22:49:56 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 17:13:59 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESMO临床实践指南:成人癌症患者临终护理.pdf)])
2021 ESMO临床实践指南:成人癌症患者临终护理.pdf
下载请点击:
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1241534, encodeId=c95a12415341c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cc4858375, createdName=yuemuxue, createdTime=Sun Aug 28 14:51:25 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202888, encodeId=4b1712028885e, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Tue Mar 15 20:55:12 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194274, encodeId=b4e211942e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:31:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194273, encodeId=3fd311942e38d, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:48 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194272, encodeId=8a8411942e2e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:29 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-08-28 yuemuxue

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1241534, encodeId=c95a12415341c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cc4858375, createdName=yuemuxue, createdTime=Sun Aug 28 14:51:25 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202888, encodeId=4b1712028885e, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Tue Mar 15 20:55:12 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194274, encodeId=b4e211942e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:31:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194273, encodeId=3fd311942e38d, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:48 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194272, encodeId=8a8411942e2e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:29 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-03-15 145a16f4m24暂无昵称

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1241534, encodeId=c95a12415341c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cc4858375, createdName=yuemuxue, createdTime=Sun Aug 28 14:51:25 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202888, encodeId=4b1712028885e, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Tue Mar 15 20:55:12 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194274, encodeId=b4e211942e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:31:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194273, encodeId=3fd311942e38d, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:48 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194272, encodeId=8a8411942e2e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:29 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-02-17 ms8000002097445321

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1241534, encodeId=c95a12415341c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cc4858375, createdName=yuemuxue, createdTime=Sun Aug 28 14:51:25 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202888, encodeId=4b1712028885e, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Tue Mar 15 20:55:12 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194274, encodeId=b4e211942e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:31:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194273, encodeId=3fd311942e38d, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:48 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194272, encodeId=8a8411942e2e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:29 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-02-17 ms8000002097445321

    学习啦

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1241534, encodeId=c95a12415341c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16cc4858375, createdName=yuemuxue, createdTime=Sun Aug 28 14:51:25 CST 2022, time=2022-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202888, encodeId=4b1712028885e, content=学, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/10/9c891de22a04ad3664335f140cf03e65.jpg, createdBy=98035075733, createdName=145a16f4m24暂无昵称, createdTime=Tue Mar 15 20:55:12 CST 2022, time=2022-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194274, encodeId=b4e211942e48b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:31:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194273, encodeId=3fd311942e38d, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:48 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194272, encodeId=8a8411942e2e3, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84d96504968, createdName=ms8000002097445321, createdTime=Thu Feb 17 01:30:29 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-02-17 ms8000002097445321

    学习

    0

拓展阅读

2021 AIOM指南:成人癌症患者的社会心理护理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2021-09-29